SYRE
Spyre Therapeutics Inc Earnings
$73.02
Earnings Summary
Revenue | $90.49Mn |
Net Profits | $-62.53Mn |
Net Profit Margins | -69.1% |
Spyre Therapeutics Inc’s revenue jumped +Inf% since last year same period to $90.49Mn in the Q4 2025. On a quarterly growth basis, Spyre Therapeutics Inc has generated +Inf% jump in its revenue since last 3-months.
Spyre Therapeutics Inc’s net profit fell -11.07% since last year same period to $-62.53Mn in the Q4 2025. On a quarterly growth basis, Spyre Therapeutics Inc has generated -459.15% fall in its net profits since last 3-months.
Spyre Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -69.1% in the Q4 2025. On a quarterly growth basis, Spyre Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.64 |
EPS Estimate Current Year | -0.64 |
Spyre Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.64 - a 8.44% jump from last quarter’s estimates.
Spyre Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.64.
Key Ratios
Earning Per Share (EPS) | 0 |
Spyre Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Spyre Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-07 | -0.64 | 0 | 100% |
